MarketPeel
Insider Trading Intelligence
AA

Arjun Agarwal

ORKA
SENIOR VICE PRESIDENT, FINANCE · ORUKA THERAPEUTICS, INC. · CIK 0002033974
FILING MIX · LIFETIME32%/68%
BUYS
7
SELLS
15
TOTAL VALUE
$1.82M
COMPANIES
1
ACTIVE SINCE
Jan 2025
HOLDINGS NOW
16,011
AVG SELL PX
$65.06
TRADE KIND
SHOWING 22 / 22
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
1 backtested trades · 8 horizons · 3 pending
Forward-return performance of every backtestable P/S trade by Arjun Agarwal, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d1+100.00%-0.46%-2.04%+1.58%+1.58%
14d1+0.00%+9.03%-5.54%+14.57%+14.57%
30d1+0.00%+57.01%+4.62%+52.39%+52.39%
60d1+0.00%+49.78%+10.95%+38.83%+38.83%
90d1+0.00%+65.25%+10.87%+54.38%+54.38%
180d1(1 pending)
1y1(1 pending)
2y1(1 pending)
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
ORKA · 16,011 shares · as of Jun 22, 2026
030,00060,00090,000120,0002026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2025
2025
2025
2025
2026
2026
FLOW · 7 buys / 15 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
888$80.01$71.0K16,011Jun 22, 2026Jun 22, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
699$82.15$57.4K15,312Jun 22, 2026Jun 22, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
395$69.69$27.5K16,899Jun 15, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
1,45962,708Jun 12, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Senior Vice President, Finance
8,000$12.50$100.0K25,294Jun 12, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Senior Vice President, Finance
1,459$34.39$50.2K26,753Jun 12, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
1,859$68.34$127.0K24,894Jun 12, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
3,260$70.34$229.3K17,294Jun 12, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,340$69.85$303.2K20,554Jun 12, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
8,000110,000Jun 12, 2026Jun 15, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
5,83364,167May 18, 2026May 18, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Senior Vice President, Finance
2,000$12.50$25.0K20,863May 18, 2026May 18, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASE
Senior Vice President, Finance
5,833$34.39$200.6K26,696May 18, 2026May 18, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,190$58.34$244.5K22,506May 18, 2026May 18, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
2,000118,000May 18, 2026May 18, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
800$60.34$48.3K17,106May 18, 2026May 18, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
4,600$59.19$272.3K17,906May 18, 2026May 18, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE10b5-1
10b5-1 plan
700$61.16$42.8K16,406May 18, 2026May 18, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
SALE
Senior Vice President, Finance
395$41.30$16.3K18,863Mar 16, 2026Mar 17, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
70,00070,000Jan 23, 2026Jan 23, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
17,50019,258Jan 23, 2026Jan 23, 2026View →
ORKA
ORUKA THERAPEUTICS, INC.
PURCHASEGRANT
Stock grant
120,000120,000Jan 22, 2025Jan 22, 2025View →
Other insiders · ORKA
Loading peer insiders…
About this filer
CIK 0002033974
ROLE
Senior Vice President, Finance
PRIMARY
ORKA
COMPANIES
1
ACTIVE SINCE
Jan 2025
MARKETPEEL · /INSIDER/0002033974DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback